Add like
Add dislike
Add to saved papers

More is more: Semi-annual breast MRI screening in BRCA1 mutation carriers.

Clinical Cancer Research 2018 November 15
Although annual MRI-screening has improved early diagnosis of hereditary breast-cancer, fast growth-rates of BRCA1-associated cancers can still lead to interval cancers, and/or node-positive disease. Using MRI with shorter screening intervals helps to effectively avoid both, interval cancers and node-positive stages, whereas there is no role for mammography in these women.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app